Journal of Neurology

, Volume 261, Issue 3, pp 620–621 | Cite as

Latin America’s first case of Perry syndrome and a new treatment option for respiratory insufficiency

  • Felipe Pretelt
  • Camilo Castañeda Cardona
  • Pawel Tacik
  • Owen A. Ross
  • Zbigniew K. WszolekEmail author
Letter to the Editors

Dear Sirs,

Perry syndrome is an autosomal dominant disorder characterized by rapidly progressive Parkinsonism, depression, weight loss, and central hypoventilation [1]. Since the original publication in 1975, only 52 patients from ten families have been found, but no case had been reported from Latin America. The mean age of symptom onset is 48 years, and the mean disease duration is 5 years. Patients usually die of respiratory complications. Genome-wide linkage analysis identified disease-segregating mutations located in exon 2 of the dynactin 1 (DCTN1) gene on chromosome 2p13 [4].

A 56-year-old Colombian female was admitted to the Hospital Universitario San Ignacio, in Bogotá, Colombia, with acute deterioration of her respiration. On clinical examination, the patient displayed generalized anxiety and a severe depressive episode. She reported a weight loss of 15 kg in 6 months. The patient had a 2-year history of Parkinsonism, which comprised hypomimia, cogwheel rigidity in all...


Chronic Obstructive Pulmonary Disease Amyotrophic Lateral Sclerosis Acute Respiratory Failure Phrenic Nerve Respiratory Insufficiency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



We thank the patient and her relatives for their assistance in realizing this manuscript.

Conflicts of interest

PT is supported by the Max Kade Foundation. ZKW is partially supported by the NIH/NINDS P50 NS072187, Mayo Clinic Center for Regenerative Medicine, and the gift from Carl Edward Bolch, Jr., and Susan Bass Bolch.

Ethical standard

This study was approved by the Institutional Review Boards of Pontificia Universidad Javeriana, Bogotá, Colombia and the Mayo Clinic and was therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.


  1. 1.
    Perry TL, Bratty PJ, Hansen S, Kennedy J, Urquhart N, Dolman CL (1975) Hereditary mental depression and Parkinsonism with taurine deficiency. Arch Neurol 32:108–113CrossRefPubMedGoogle Scholar
  2. 2.
    Wider C, Dachsel JC, Farrer MJ, Dickson DW, Tsuboi Y, Wszolek ZK (2010) Elucidating the genetics and pathology of Perry syndrome. J Neurol Sci 15(289):149–154CrossRefGoogle Scholar
  3. 3.
    Aji BM, Medley G, O’Driscoll K, Larner AJ, Alusi SH (2013) Perry syndrome: a disorder to consider in the differential diagnosis of Parkinsonism. J Neurol Sci 330:117–118CrossRefPubMedGoogle Scholar
  4. 4.
    Farrer MJ, Hulihan MM, Kachergus JM et al (2009) DCTN1 mutations in Perry syndrome. Nat Genet 412:163–165CrossRefGoogle Scholar
  5. 5.
    Domanski MC, Preciado DA (2012) Vocal cord collapse during phrenic nerve-paced respiration in congenital central hypoventilation syndrome. F1000Res. 1:42. doi: 10.12688/f1000research.1-42.v1
  6. 6.
    Son BC, Kim DR, Kim IS, Hong JT (2013) Phrenic nerve stimulation for diaphragm pacing in a quadriplegic patient. J Korean Neurosurg Soc 54:359–362CrossRefPubMedCentralPubMedGoogle Scholar
  7. 7.
    Approval Letter from the Department of Health & Human Services of the Food and Drug Administration to Synapse Biomedical Inc., NeuRx Diaphragm Pacing System™. Accessed 28 Sept 2011Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Felipe Pretelt
    • 1
  • Camilo Castañeda Cardona
    • 1
  • Pawel Tacik
    • 2
  • Owen A. Ross
    • 3
  • Zbigniew K. Wszolek
    • 2
    Email author
  1. 1.Department of NeurologyHospital Universitario San Ignacio, Pontificia Universidad JaverianaBogotáColombia
  2. 2.Department of NeurologyMayo ClinicJacksonvilleUSA
  3. 3.Department of NeuroscienceMayo ClinicJacksonvilleUSA

Personalised recommendations